Search
for
Sort by
Research 61–90 of 1000+
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Application of Baricitinib in Dermatology
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Spotlight in Plastic Surgery: October 2022
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion